# Arthralgia During Anastrozole Therapy for Breast Cancer

> **NCT00323479** · PHASE4 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 114 (actual)

## Conditions studied

- Early Breast Cancer

## Interventions

- **DRUG:** Anastrozole

## Key facts

- **NCT ID:** NCT00323479
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 114 (ACTUAL)
- **Last updated:** 2012-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00323479

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00323479, "Arthralgia During Anastrozole Therapy for Breast Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00323479. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*